May 4, 2023... The FDA licensed the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making.
May 4, 2023... In a first, a team from Brigham and Women’s Hospital and Boston Children’s Hospital successfully treated a vascular malformation in an infant’s brain before birth.
May 3, 2023... A gathering of experts in CAR-T cancer therapy at #STAT breakthrough express optimism about making therapy faster and more accessible, while also raising concerns about falling behind China.
May 3, 2023... "Probably any words I use to describe my emotions at seeing this data will understate it," said Daniel Skovronsky, Eli Lilly's head scientist.
May 3, 2023... The FDA has approved the first-ever vaccine for respiratory syncytial virus, or RSV, completing an elusive quest that has been decades in the making.
May 3, 2023... A new Eli Lilly Alzheimer's treatment slowed the rate of cognitive and functional decline in patients by 35% compared to placebo.
May 3, 2023... A drug approved in November as the first new treatment for advanced ovarian cancer in over seven years has now been shown to extend patients’ lives, its developer, Immunogen, said Wednesday.
May 2, 2023... A Senate health committee markup on PBM reform was rocky from the start — and downhill from there.
May 2, 2023... Eli Lilly is nearing the readout from a pivotal study of its experimental treatment for Alzheimer’s disease. Here's what to know.
May 2, 2023... The toxic chemicals used in salad bowls and French fry pouches may be leaching into food, despite efforts to make those materials safer.
May 1, 2023... Japanese drugmaker Astellas said it would acquire eye drug developer Iveric Bio for $5.9 billion, betting on a prospective treatment for a form of vision loss that affects around 1 million people in the U.S.
May 1, 2023... You've probably heard of Ozempic and even Mounjaro. But a clutch of startups say they'll have even better, or at least less nauseating, drugs for weight loss.
April 28, 2023... “I'm not hopeful because lockdowns seem like our new normal,” said one prisoner who's advocating for more mental health services to help release stress and promote rehabilitation.
April 27, 2023... In public, hospitals rave about artificial intelligence. But on the front lines, the hype is smashing into a starkly different reality.
April 25, 2023... An experimental oral medicine to treat ulcerative colitis showed promise — and blockbuster potential — in a new study.
April 24, 2023... "We believe the best way to end animal testing is to pump up alternative R&D testing methods,” said Victoria Katrinak of the Humane Society.
April 24, 2023... Donald Trump showed us how dangerous it is to dismiss a conspiracy theorist with a chip on his shoulder and a famous name.
April 24, 2023... The European Commission on Wednesday will soon release draft legislation that could transform the way medicines are brought to market across the continent.
April 21, 2023... The U.S. Supreme Court on Friday ruled 7-2 that a commonly used abortion pill could stay on the market pending further legal review.
April 20, 2023... It is reckless for courts to make decisions that disregard decades of clinical evidence on drug safety and effectiveness.
April 20, 2023... The federal government has burned through more than $1 billion to study long Covid, and there's basically nothing to show for it.
April 19, 2023... More than two-thirds of people in the U.S. who know about RSV said they're worried their kids will contract the virus.
April 19, 2023... A drug by Relay Therapeutics shows it can attack breast cancer cells without causing a common toxic side effect. But it did little to slow progression.
April 17, 2023... Realizing the benefits of animals with intentional genomic alterations depends on gaining consumers’ trust, which in turn requires a regulatory system that consumers can count on.
April 17, 2023... For Sarepta, an experimental gene therapy is a story of foresight, savvy dealmaking, scientific puzzle solving, and perseverance.
April 14, 2023... U.S. telehealth abortion providers scrambled after a court ruled the abortion pill mifepristone could be distributed only after in-person doctor visits.
April 14, 2023... Adding transparency to the supply chain is crucial to give people access to essential medications
April 13, 2023... Ghana on Thursday became the first country to approve a new malaria vaccine for young children, one that officials hope will offer better protection against the disease that kills hundreds of thousands every year.
April 13, 2023... A federal appeals court is allowing continued access to a common abortion medication, mifepristone, but with some additional restrictions.
